- $4.98m
- $5.20m
- $15.71m
- 28
- 51
- 33
- 30
Annual balance sheet for CV Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 4.02 | 1.38 | 0.611 | 1.32 | 0.454 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.13 | 2.04 | 0.766 | 0.431 | 0.522 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 16.9 | 14.2 | 11.1 | 7.94 | 6.24 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5.93 | 1.72 | 0.85 | 0.546 | 0.493 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 30.6 | 18.1 | 12.7 | 9.2 | 7.93 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 14.3 | 14.5 | 13.3 | 6.12 | 6.11 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 19.4 | 14.5 | 13.5 | 6.3 | 6.13 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 11.2 | 3.54 | -0.777 | 2.9 | 1.79 |
Total Liabilities & Shareholders' Equity | 30.6 | 18.1 | 12.7 | 9.2 | 7.93 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |